Cannabix Technologies has the exclusive North American license for the Cannabix Marijuana Breathalyzer.
Cannabix Technologies has raised $1.4M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in November 2025.
Cannabix Technologies is headquartered in Burnaby, Canada.
Cannabix Technologies has the exclusive North American license for the Cannabix Marijuana Breathalyzer.
Cannabix Technologies is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cannabix Technologies — Funding & Investors." VCBacked, November 7, 2025, https://www.vcbacked.co/company/cannabix-technologies. Accessed August 15, 2026.
VCBacked. (2025). Cannabix Technologies — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/cannabix-technologies
{{cite web |title=Cannabix Technologies — Funding & Investors |url=https://www.vcbacked.co/company/cannabix-technologies |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated